期刊文献+

应用普伐他汀钠治疗慢性心力衰竭 被引量:1

下载PDF
导出
摘要 目的:探讨普伐他汀钠对慢性心力衰竭的治疗效果。方法:2009年1月-2009年12月于我科入院或门诊的74例慢性心力衰竭患者,随机分为普伐他汀钠治疗组(38例)和对照组(36例),对照组给予强心、利尿、扩血管治疗,治疗组在此基础上加用普伐他汀,剂量为20mg,每晚1次,疗程8个月,测定左室射血分数(LVEF)、左室舒张末内径(LVEDD)、左室收缩末内径(LVESD),统计两组治疗后症状改善率、再住院率、死亡率。结果:普伐他汀钠治疗组与对照组比较,治疗后两组左室射血分数均有所提高,左室收缩末内径均有缩小,但普伐他汀组明显,与对照组比较,有统计学差异;普伐他汀钠组症状改善率、心衰再住院率、死亡率下降更明显,两组比较有统计学差异。结论:普伐他汀钠能改善慢性心衰患者的心功能、并使患者住院率、死亡率明显下降。
出处 《中国民族民间医药》 2010年第24期104-104,共1页 Chinese Journal of Ethnomedicine and Ethnopharmacy
  • 相关文献

参考文献3

  • 1Ho KKL,Anderson KM,Kannel WB.Sunvival after the onset of congestive heart failure in Framingham Heart Study subjects[J].Circulation,1993,88(1):107.
  • 2胡大一,吴彦.规范心力衰竭治疗 加强患者管理[J].中华心血管病杂志,2005,33(6):495-497. 被引量:124
  • 3LIPID Study Group.Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J].N Engl J Med,1998,339(19):1349-1357.

二级参考文献10

  • 1Stewart S, Maclntyre K, Macleod MM, et al. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J,2001, 22:209-217.
  • 2Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J,2001,22:1527-1560.
  • 3Felker GM, Adams KF Jr, Konstam MA, et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J,2003,145:S18-S25.
  • 4Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail,2001,3:283-291.
  • 5Coletta AP, Cleland JG, Freemantle N, et al. Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM. Eur J Heart Fail,2003,5:697-704.
  • 6Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005, 352:225-237.
  • 7Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005,352:1539-1549.
  • 8Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet,2004 ,364:141-148.
  • 9Arnold JM, Yusuf S, Young J, et al. HOPE Investigators. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation,2003,107:1284-1290.
  • 10Fox KM. European trial on reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet,2003,362:782-788.

共引文献123

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部